A nonprofit led by the co-founder and former CEO of 23andMe outbid competitors for nearly all of the company’s assets.

The agency cleared CSL’s hereditary angioedema drug days after “resource constraints” delayed a rival medicine. Elsewhere, ...

Anne Wojcicki's winning bid to reclaim control of 23andMe doesn't necessarily end the fight over what happens to the DNA of 15 million people collected by the bankrupt consumer genomics company.

James Moss, the director of cyber investigations at law firm Addleshaw Goddard, told Sky News the ICO's fine was "about as ...

The Information Commissioner's Office (ICO) has levied a £2.31 million ($3.13 million) penalty on the Californian company in connection with a cyberattack in 2023 that resulted in the personal ...

Embattled genetic testing company 23andMe has been fined £2.3m ($3.1m) by the UK’s privacy regulator for failing to protect ...

The UK's data watchdog is fining beleaguered DNA testing outfit 23andMe £2.31 million ($3.13 million) over its 2023 mega ...

Regeneron Pharmaceuticals (NASDAQ:REGN) has reportedly declined to submit a higher bid for 23andMe (OTC:MEHCQ) after a ...

Bankrupt testing firm 23andMe has been fined more than £2m for failing to protect sensitive personal and genetic data of UK ...

The fine comes as the DNA testing firm, which filed for bankruptcy in March, is set to be sold to a new owner.

The Information Commissioner's Office (ICO) has fined genetic testing company 23andMe £2.31m for failing to implement appropriate security measures to protect the ...

A 2023 breach of genetic testing company 23andMe that leaked sensitive data for millions of customers already led to a $30 ...